0

CNS-1102

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATIAR4242814
MDL NumberMFCD00867728
Molecular Weight339.86
InChI KeyCKAKVKWRMCAYJD-UHFFFAOYSA-N
Description>98% (HPLC), solid
SolubilityH2O: soluble 17 mg/mL; DMSO: soluble 20 mg/mL
Assay>98% (HPLC)
Colorwhite
Formsolid
Size10MG
Storage Conditions2-8°C
1

Clinical Pharmacology of CNS 1102 in Man

K W Muir, D G Grosset, K R Lees

Ann N Y Acad Sci. 1995 Sep 15;765:336-7.

PMID: 7486638

1

Clinical Pharmacology of CNS 1102 in Volunteers

K W Muir, D G Grosset, K R Lees

Ann N Y Acad Sci. 1995 Sep 15;765:279-89; discussion 298.

PMID: 7486614

1

Pharmacological Effects of the Non-Competitive NMDA Antagonist CNS 1102 in Normal Volunteers

K W Muir, D G Grosset, E Gamzu, K R Lees

Br J Clin Pharmacol. 1994 Jul;38(1):33-8.

PMID: 7946934

1

Systemic and Cerebral Hemodynamic Responses to the Noncompetitive N-methyl-D-aspartate (NMDA) Antagonist CNS 1102

D G Grosset, K W Muir, K R Lees

J Cardiovasc Pharmacol. 1995 May;25(5):705-9.

PMID: 7630148

1

The N-methyl-D-aspartate Antagonist CNS 1102 Protects Cerebral Gray and White Matter From Ischemic Injury Following Temporary Focal Ischemia in Rats

W R Schäbitz, F Li, M Fisher

Stroke. 2000 Jul;31(7):1709-14.

PMID: 10884477

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode